Dr. Dai currently serves as Vice Chair of Physical Pharmacy and Biopharmaceutics (PPB) section in AAPS. Additionally, he is the current President of Sino-American Pharmaceutical Professionals Association (SAPA)-Greater Philadelphia. SAPA is a nonprofit and pharmaceutical professional organization with over 4,000 members.
Dr. Dai’s research and innovation have focused on improving both biological and small molecule drug products through design and development of novel formulations, proprietary delivery technologies and processes. His technology innovations have directly led to the launch of a current commercial delivery-enhanced product by Johnson and Johnson, and established the development projects for clinical trials.